【市場調査レポート】非感染性ブドウ膜炎治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Non-infectious Uveitis Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。非感染性ブドウ膜炎治療のグローバル市場インサイト・予測（～2028年） / Global Non-infectious Uveitis Treatment Market Insights, Forecast to 2028 / QY2207E09261資料のイメージです。

• レポートコード：QY2207E09261
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の非感染性ブドウ膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非感染性ブドウ膜炎治療の世界市場のxxx％を占める「ステロイド薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の非感染性ブドウ膜炎治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの非感染性ブドウ膜炎治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの非感染性ブドウ膜炎治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

非感染性ブドウ膜炎治療のグローバル主要メーカーには、Bausch & Lomb、Santen Pharmaceutical、AbbVie、Novartis、Eyegate Pharmaceuticals、Regeneron Pharmaceuticals、Eyepoint pharmaceuticals、Alimera Sciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

非感染性ブドウ膜炎治療市場は、種類と用途によって区分されます。世界の非感染性ブドウ膜炎治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ステロイド薬、免疫抑制薬、その他

【用途別セグメント】
病院、眼科クリニック、在宅治療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 非感染性ブドウ膜炎治療製品概要
- 種類別市場（ステロイド薬、免疫抑制薬、その他）
- 用途別市場（病院、眼科クリニック、在宅治療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の非感染性ブドウ膜炎治療販売量予測2017-2028
- 世界の非感染性ブドウ膜炎治療売上予測2017-2028
- 非感染性ブドウ膜炎治療の地域別販売量
- 非感染性ブドウ膜炎治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別非感染性ブドウ膜炎治療販売量
- 主要メーカー別非感染性ブドウ膜炎治療売上
- 主要メーカー別非感染性ブドウ膜炎治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ステロイド薬、免疫抑制薬、その他）
- 非感染性ブドウ膜炎治療の種類別販売量
- 非感染性ブドウ膜炎治療の種類別売上
- 非感染性ブドウ膜炎治療の種類別価格
・用途別市場規模（病院、眼科クリニック、在宅治療、その他）
- 非感染性ブドウ膜炎治療の用途別販売量
- 非感染性ブドウ膜炎治療の用途別売上
- 非感染性ブドウ膜炎治療の用途別価格
・北米市場
- 北米の非感染性ブドウ膜炎治療市場規模（種類別、用途別）
- 主要国別の非感染性ブドウ膜炎治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの非感染性ブドウ膜炎治療市場規模（種類別、用途別）
- 主要国別の非感染性ブドウ膜炎治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の非感染性ブドウ膜炎治療市場規模（種類別、用途別）
- 主要国別の非感染性ブドウ膜炎治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の非感染性ブドウ膜炎治療市場規模（種類別、用途別）
- 主要国別の非感染性ブドウ膜炎治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの非感染性ブドウ膜炎治療市場規模（種類別、用途別）
- 主要国別の非感染性ブドウ膜炎治療市場規模（トルコ、サウジアラビア）
・企業情報
Bausch & Lomb、Santen Pharmaceutical、AbbVie、Novartis、Eyegate Pharmaceuticals、Regeneron Pharmaceuticals、Eyepoint pharmaceuticals、Alimera Sciences
・産業チェーン及び販売チャネル分析
- 非感染性ブドウ膜炎治療の産業チェーン分析
- 非感染性ブドウ膜炎治療の原材料
- 非感染性ブドウ膜炎治療の生産プロセス
- 非感染性ブドウ膜炎治療の販売及びマーケティング
- 非感染性ブドウ膜炎治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 非感染性ブドウ膜炎治療の産業動向
- 非感染性ブドウ膜炎治療のマーケットドライバー
- 非感染性ブドウ膜炎治療の課題
- 非感染性ブドウ膜炎治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Non-infectious Uveitis Treatment Market
The global Non-infectious Uveitis Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Steroids Drug accounting for % of the Non-infectious Uveitis Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Non-infectious Uveitis Treatment market size is valued at US$ million in 2021, while the North America and Europe Non-infectious Uveitis Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non-infectious Uveitis Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-infectious Uveitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-infectious Uveitis Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-infectious Uveitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-infectious Uveitis Treatment market.
Global Non-infectious Uveitis Treatment Scope and Market Size
Non-infectious Uveitis Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Non-infectious Uveitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Steroids Drug
Immunosuppressant Drug
Others
Segment by Application
Hospitals
Eye Clinics
Home Treatment
Others
By Company
Bausch & Lomb
Santen Pharmaceutical
AbbVie
Novartis
Eyegate Pharmaceuticals
Regeneron Pharmaceuticals
Eyepoint pharmaceuticals
Alimera Sciences
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-infectious Uveitis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Steroids Drug
1.2.3 Immunosuppressant Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Non-infectious Uveitis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Home Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-infectious Uveitis Treatment Market Perspective (2017-2028)
2.2 Non-infectious Uveitis Treatment Growth Trends by Region
2.2.1 Non-infectious Uveitis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-infectious Uveitis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Non-infectious Uveitis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Non-infectious Uveitis Treatment Market Dynamics
2.3.1 Non-infectious Uveitis Treatment Industry Trends
2.3.2 Non-infectious Uveitis Treatment Market Drivers
2.3.3 Non-infectious Uveitis Treatment Market Challenges
2.3.4 Non-infectious Uveitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-infectious Uveitis Treatment Players by Revenue
3.1.1 Global Top Non-infectious Uveitis Treatment Players by Revenue (2017-2022)
3.1.2 Global Non-infectious Uveitis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Non-infectious Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-infectious Uveitis Treatment Revenue
3.4 Global Non-infectious Uveitis Treatment Market Concentration Ratio
3.4.1 Global Non-infectious Uveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-infectious Uveitis Treatment Revenue in 2021
3.5 Non-infectious Uveitis Treatment Key Players Head office and Area Served
3.6 Key Players Non-infectious Uveitis Treatment Product Solution and Service
3.7 Date of Enter into Non-infectious Uveitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-infectious Uveitis Treatment Breakdown Data by Type
4.1 Global Non-infectious Uveitis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Non-infectious Uveitis Treatment Forecasted Market Size by Type (2023-2028)
5 Non-infectious Uveitis Treatment Breakdown Data by Application
5.1 Global Non-infectious Uveitis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Non-infectious Uveitis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-infectious Uveitis Treatment Market Size (2017-2028)
6.2 North America Non-infectious Uveitis Treatment Market Size by Type
6.2.1 North America Non-infectious Uveitis Treatment Market Size by Type (2017-2022)
6.2.2 North America Non-infectious Uveitis Treatment Market Size by Type (2023-2028)
6.2.3 North America Non-infectious Uveitis Treatment Market Share by Type (2017-2028)
6.3 North America Non-infectious Uveitis Treatment Market Size by Application
6.3.1 North America Non-infectious Uveitis Treatment Market Size by Application (2017-2022)
6.3.2 North America Non-infectious Uveitis Treatment Market Size by Application (2023-2028)
6.3.3 North America Non-infectious Uveitis Treatment Market Share by Application (2017-2028)
6.4 North America Non-infectious Uveitis Treatment Market Size by Country
6.4.1 North America Non-infectious Uveitis Treatment Market Size by Country (2017-2022)
6.4.2 North America Non-infectious Uveitis Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-infectious Uveitis Treatment Market Size (2017-2028)
7.2 Europe Non-infectious Uveitis Treatment Market Size by Type
7.2.1 Europe Non-infectious Uveitis Treatment Market Size by Type (2017-2022)
7.2.2 Europe Non-infectious Uveitis Treatment Market Size by Type (2023-2028)
7.2.3 Europe Non-infectious Uveitis Treatment Market Share by Type (2017-2028)
7.3 Europe Non-infectious Uveitis Treatment Market Size by Application
7.3.1 Europe Non-infectious Uveitis Treatment Market Size by Application (2017-2022)
7.3.2 Europe Non-infectious Uveitis Treatment Market Size by Application (2023-2028)
7.3.3 Europe Non-infectious Uveitis Treatment Market Share by Application (2017-2028)
7.4 Europe Non-infectious Uveitis Treatment Market Size by Country
7.4.1 Europe Non-infectious Uveitis Treatment Market Size by Country (2017-2022)
7.4.2 Europe Non-infectious Uveitis Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-infectious Uveitis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Type
8.2.1 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-infectious Uveitis Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Application
8.3.1 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-infectious Uveitis Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Region
8.4.1 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-infectious Uveitis Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-infectious Uveitis Treatment Market Size (2017-2028)
9.2 Latin America Non-infectious Uveitis Treatment Market Size by Type
9.2.1 Latin America Non-infectious Uveitis Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Non-infectious Uveitis Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Non-infectious Uveitis Treatment Market Share by Type (2017-2028)
9.3 Latin America Non-infectious Uveitis Treatment Market Size by Application
9.3.1 Latin America Non-infectious Uveitis Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Non-infectious Uveitis Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Non-infectious Uveitis Treatment Market Share by Application (2017-2028)
9.4 Latin America Non-infectious Uveitis Treatment Market Size by Country
9.4.1 Latin America Non-infectious Uveitis Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Non-infectious Uveitis Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-infectious Uveitis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Type
10.2.1 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-infectious Uveitis Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Application
10.3.1 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-infectious Uveitis Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Country
10.4.1 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-infectious Uveitis Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bausch & Lomb
11.1.1 Bausch & Lomb Company Details
11.1.2 Bausch & Lomb Business Overview
11.1.3 Bausch & Lomb Non-infectious Uveitis Treatment Introduction
11.1.4 Bausch & Lomb Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.1.5 Bausch & Lomb Recent Developments
11.2 Santen Pharmaceutical
11.2.1 Santen Pharmaceutical Company Details
11.2.2 Santen Pharmaceutical Business Overview
11.2.3 Santen Pharmaceutical Non-infectious Uveitis Treatment Introduction
11.2.4 Santen Pharmaceutical Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.2.5 Santen Pharmaceutical Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Non-infectious Uveitis Treatment Introduction
11.3.4 AbbVie Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.3.5 AbbVie Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Non-infectious Uveitis Treatment Introduction
11.4.4 Novartis Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Eyegate Pharmaceuticals
11.5.1 Eyegate Pharmaceuticals Company Details
11.5.2 Eyegate Pharmaceuticals Business Overview
11.5.3 Eyegate Pharmaceuticals Non-infectious Uveitis Treatment Introduction
11.5.4 Eyegate Pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.5.5 Eyegate Pharmaceuticals Recent Developments
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Non-infectious Uveitis Treatment Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.6.5 Regeneron Pharmaceuticals Recent Developments
11.7 Eyepoint pharmaceuticals
11.7.1 Eyepoint pharmaceuticals Company Details
11.7.2 Eyepoint pharmaceuticals Business Overview
11.7.3 Eyepoint pharmaceuticals Non-infectious Uveitis Treatment Introduction
11.7.4 Eyepoint pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.7.5 Eyepoint pharmaceuticals Recent Developments
11.8 Alimera Sciences
11.8.1 Alimera Sciences Company Details
11.8.2 Alimera Sciences Business Overview
11.8.3 Alimera Sciences Non-infectious Uveitis Treatment Introduction
11.8.4 Alimera Sciences Revenue in Non-infectious Uveitis Treatment Business (2017-2022)
11.8.5 Alimera Sciences Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Non-infectious Uveitis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Steroids Drug
Table 3. Key Players of Immunosuppressant Drug
Table 4. Key Players of Others
Table 5. Global Non-infectious Uveitis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Non-infectious Uveitis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Non-infectious Uveitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Non-infectious Uveitis Treatment Market Share by Region (2017-2022)
Table 9. Global Non-infectious Uveitis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Non-infectious Uveitis Treatment Market Share by Region (2023-2028)
Table 11. Non-infectious Uveitis Treatment Market Trends
Table 12. Non-infectious Uveitis Treatment Market Drivers
Table 13. Non-infectious Uveitis Treatment Market Challenges
Table 14. Non-infectious Uveitis Treatment Market Restraints
Table 15. Global Non-infectious Uveitis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Non-infectious Uveitis Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Non-infectious Uveitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Uveitis Treatment as of 2021)
Table 18. Ranking of Global Top Non-infectious Uveitis Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Non-infectious Uveitis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Non-infectious Uveitis Treatment Product Solution and Service
Table 22. Date of Enter into Non-infectious Uveitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Non-infectious Uveitis Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Non-infectious Uveitis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Non-infectious Uveitis Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Non-infectious Uveitis Treatment Revenue Share by Application (2017-2022)
Table 30. Global Non-infectious Uveitis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Non-infectious Uveitis Treatment Revenue Share by Application (2023-2028)
Table 32. North America Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Non-infectious Uveitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Non-infectious Uveitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Non-infectious Uveitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Non-infectious Uveitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Non-infectious Uveitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Non-infectious Uveitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Non-infectious Uveitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Non-infectious Uveitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Non-infectious Uveitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Non-infectious Uveitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Non-infectious Uveitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Non-infectious Uveitis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Non-infectious Uveitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Non-infectious Uveitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Non-infectious Uveitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Non-infectious Uveitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Non-infectious Uveitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Bausch & Lomb Company Details
Table 63. Bausch & Lomb Business Overview
Table 64. Bausch & Lomb Non-infectious Uveitis Treatment Product
Table 65. Bausch & Lomb Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 66. Bausch & Lomb Recent Developments
Table 67. Santen Pharmaceutical Company Details
Table 68. Santen Pharmaceutical Business Overview
Table 69. Santen Pharmaceutical Non-infectious Uveitis Treatment Product
Table 70. Santen Pharmaceutical Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 71. Santen Pharmaceutical Recent Developments
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Non-infectious Uveitis Treatment Product
Table 75. AbbVie Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 76. AbbVie Recent Developments
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Non-infectious Uveitis Treatment Product
Table 80. Novartis Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 81. Novartis Recent Developments
Table 82. Eyegate Pharmaceuticals Company Details
Table 83. Eyegate Pharmaceuticals Business Overview
Table 84. Eyegate Pharmaceuticals Non-infectious Uveitis Treatment Product
Table 85. Eyegate Pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 86. Eyegate Pharmaceuticals Recent Developments
Table 87. Regeneron Pharmaceuticals Company Details
Table 88. Regeneron Pharmaceuticals Business Overview
Table 89. Regeneron Pharmaceuticals Non-infectious Uveitis Treatment Product
Table 90. Regeneron Pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 91. Regeneron Pharmaceuticals Recent Developments
Table 92. Eyepoint pharmaceuticals Company Details
Table 93. Eyepoint pharmaceuticals Business Overview
Table 94. Eyepoint pharmaceuticals Non-infectious Uveitis Treatment Product
Table 95. Eyepoint pharmaceuticals Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 96. Eyepoint pharmaceuticals Recent Developments
Table 97. Alimera Sciences Company Details
Table 98. Alimera Sciences Business Overview
Table 99. Alimera Sciences Non-infectious Uveitis Treatment Product
Table 100. Alimera Sciences Revenue in Non-infectious Uveitis Treatment Business (2017-2022) & (US$ Million)
Table 101. Alimera Sciences Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-infectious Uveitis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Steroids Drug Features
Figure 3. Immunosuppressant Drug Features
Figure 4. Others Features
Figure 5. Global Non-infectious Uveitis Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Eye Clinics Case Studies
Figure 8. Home Treatment Case Studies
Figure 9. Others Case Studies
Figure 10. Non-infectious Uveitis Treatment Report Years Considered
Figure 11. Global Non-infectious Uveitis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Non-infectious Uveitis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Non-infectious Uveitis Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Non-infectious Uveitis Treatment Market Share by Players in 2021
Figure 15. Global Top Non-infectious Uveitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Uveitis Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Non-infectious Uveitis Treatment Revenue in 2021
Figure 17. North America Non-infectious Uveitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Non-infectious Uveitis Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Non-infectious Uveitis Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Non-infectious Uveitis Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Non-infectious Uveitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Non-infectious Uveitis Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Non-infectious Uveitis Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Non-infectious Uveitis Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Non-infectious Uveitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Non-infectious Uveitis Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Non-infectious Uveitis Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Non-infectious Uveitis Treatment Market Size Share by Region (2017-2028)
Figure 37. China Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Non-infectious Uveitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Non-infectious Uveitis Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Non-infectious Uveitis Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Non-infectious Uveitis Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Non-infectious Uveitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Non-infectious Uveitis Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Non-infectious Uveitis Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Non-infectious Uveitis Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Non-infectious Uveitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Bausch & Lomb Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 57. Santen Pharmaceutical Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 58. AbbVie Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 60. Eyegate Pharmaceuticals Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 62. Eyepoint pharmaceuticals Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 63. Alimera Sciences Revenue Growth Rate in Non-infectious Uveitis Treatment Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

感染症POC診断のグローバル市場インサイト・予測（～2028年）

Global Infectious Disease POC Diagnostic Market Insights, Forecast to 2028
QY2207E09587 2022年7月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の感染症POC診断の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に感染症POC診断の世...

単純疱疹治療のグローバル市場インサイト・予測（～2028年）

Global Cold Sore Treatment Market Insights, Forecast to 2028
QY2207C3477 2022年7月11日 127Pages
新型コロナウイルス感染症のパンデミックにより、世界の単純疱疹治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に単純疱疹治療の世界市場の...

眼がん治療のグローバル市場インサイト・予測（～2028年）

Global Eye Cancer Treatment Market Insights, Forecast to 2028
QY2207C3457 2022年7月11日 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の眼がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼がん治療の世界市場のxx...

カタレプシー治療のグローバル市場インサイト・予測（～2028年）

Global Catalepsy Treatment Market Insights, Forecast to 2028
QY2207C3470 2022年7月11日 125Pages
新型コロナウイルス感染症のパンデミックにより、世界のカタレプシー治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカタレプシー治療の世...

地図状萎縮治療のグローバル市場インサイト・予測（～2028年）

Global Geographic Atrophy Treatment Market Insights, Forecast to 2028
QY2207C3463 2022年7月11日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の地図状萎縮治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に地図状萎縮治療の世界市...

結膜炎治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Conjunctivitis Treatment Market The global Conjunctivitis Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Antibiotic accountin…
糖尿病性眼疾患治療のグローバル市場インサイト・予測（～2028年） Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contr…
眼がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Eye Cancer Treatment Market The global Eye Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the…
脳がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Brain Cancer Treatment Market The global Brain Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Chemotherapy accounting …
感染症POC診断のグローバル市場インサイト・予測（～2028年） Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC t…